https://www.hcplive.com/view/tirzepatide-vs-semaglutide-tina-thethi-differences-seen-diabetes-obesity
0
0
Tirzepatide vs. Semaglutide: Tina Thethi, MD, Details the Differences Seen in Diabetes, Obesity - MD Magazine
10/16/22 at 2:29pm
Organization
Hcplive.com
Author
Giuliana Grossi
Details
39 words
Summarize
Health Diabetes Semaglutide Tina Thethi tirzepatide GLP-1 Obesity - MD Magazine combination drug Pri-Med
The ongoing buzz around GLP-1 RAs, like semaglutide, and now the GIP combination drug tirzepatide, reached a summit at Pri-Med Midwest 2022.
Create an account or login to join the discussion